A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HNC / head and neck cancer

[Related PubMed/MEDLINE]
Total Number of Papers: 2022
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HNC  (>> Co-occurring Abbreviation)
Long Form:   head and neck cancer
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 "Completely and utterly flummoxed and out of my depth": patient and caregiver experiences during and after treatment for head and neck cancer-a qualitative evaluation of barriers and facilitators to best-practice nutrition care. MOC
2020 18F-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis. AoA, LCC, Pre-RT, RT
2020 A comparative study between open-face and closed-face masks for head and neck cancer (HNC) in radiation therapy. CBCT, CHR, CHSM, HN, OHSM, SD, SHR
2020 A nationwide population-based study to access the risk of metachronous esophageal cancers in head and neck cancer survivors. ---
2020 A PI3K/AKT Scaffolding Protein, IQ Motif-Containing GTPase Associating Protein 1 (IQGAP1), Promotes Head and Neck Carcinogenesis. 4NQO, IQGAP1, IQGAP1
2020 A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice. VHNSS-IT
2020 A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods. MOTDs, PROs, RT
2020 A randomized phase III trial for alleviating radiation-induced xerostomia with chewing gum. RT
2020 A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer. CRT, QOL
10  2020 Access to a regular medical provider among head and neck cancer survivors. CI
11  2020 Adverse respiratory outcomes among head and neck cancer survivors in the Utah Cancer Survivors Study. CI, HR
12  2020 Alcohol-related head and neck cancer: Summary of the literature. ---
13  2020 Alterations in genetic pathways following radiotherapy for head and neck cancer. RT
14  2020 Analyses of integrated EPID images for on-treatment quality assurance to account for interfractional variations in volumetric modulated arc therapy. EPID, PC, VMAT
15  2020 Assessing patient-reported symptom burden of long-term head and neck cancer survivors at annual surveillance in survivorship clinic. MDASI-HN
16  2020 Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population? EQ VAS, HRQoL
17  2020 Association Between Pharyngeal Pooling and Aspiration Using Fiberoptic Endoscopic Evaluation of Swallowing in Head and Neck Cancer Patients with Dysphagia. FEES
18  2020 Association of Diabetes with Oral Cancer- an Enigmatic Correlation. CI, DM, OR, OR, OR
19  2020 Attitudes of Clinicians about Screening Head and Neck Cancer Survivors for Lung Cancer Using Low-Dose Computed Tomography. LCS, LDCT, SDM
20  2020 Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developments. IA, IMRT, OS
21  2020 Changes in Nutrition Impact Symptoms, Nutritional and Functional Status during Head and Neck Cancer Treatment. NIS, ONS, PG-SGA
22  2020 Circulating Tumor DNA in Saliva in an Orthotopic Head and Neck Cancer Mouse Model. ctDNA, hLINE
23  2020 Clinical pharmacokinetics and drug exposure-toxicity correlation study of docetaxel based chemotherapy in Chinese head and neck cancer patients. AUC, BSA, MPE, PK
24  2020 Complex reconstruction technique applied in advanced head and neck cancer. ---
25  2020 Demographic, clinical and lifestyle-related correlates of accelerometer assessed physical activity and fitness in newly diagnosed patients with head and neck cancer. ---
26  2020 Dentition, nutritional status and adequacy of dietary intake in treatment naive head and neck cancer patients. DI, EI, NIS, WL
27  2020 Detection, prediction, and prognosis: blood circulating microRNA as novel molecular markers of head and neck cancer patients. miRNAs
28  2020 Dietary glycaemic index, glycaemic load and head and neck cancer risk: a pooled analysis in an international consortium. CIs, GI, GL, INHANCE, ORs
29  2020 Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer. DLD, KGDH, ROS, shRNA, siRNA
30  2020 Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic. PPE
31  2020 EAT-10 Scores and Fiberoptic Endoscopic Evaluation of Swallowing in Head and Neck Cancer Patients. EAT, FEES, OD
32  2020 Effectiveness of Adjunctive Analgesics in Head and Neck Cancer Patients Receiving Curative (Chemo-) Radiotherapy: A Systematic Review. ---
33  2020 Effects of early nutritional intervention on oral mucositis in patients with radiotherapy for head and neck cancer. BMI, PG-SGA, RT
34  2020 Efficacy of Melatonin in prevention of radiation-induced oral mucositis: A randomized clinical trial. TAC
35  2020 Electrochemical genosensor based on carbon nanotube/amine-ionic liquid functionalized reduced graphene oxide nanoplatform for detection of human papillomavirus (HPV16)-related head and neck cancer. DPV, GA, MWCNT
36  2020 Electronic tumor board presentations as the basis for the development of a head and neck cancer database. TBs
37  2020 Epidemiological Correlations Between Head and Neck Cancer and Hepatitis B Core Antibody Positivity. CI, HBc, HBV, OR
38  2020 Epidemiology of head and neck cancers: an update. HPV
39  2020 Epigenetic Modification of CFTR in Head and Neck Cancer. cAMP, CFTR
40  2020 Estimating PTV Margins in Head and Neck Stereotactic Ablative Radiation Therapy (SABR) Through Target Site Analysis of Positioning and Intrafractional Accuracy. CBCT, PTV, SABR
41  2020 Ethical considerations in screening head and neck cancer patients for psychosocial distress. SFD
42  2020 Evaluating for disparities in place of death for head and neck cancer patients in the United States utilizing the CDC WONDER database. MLR
43  2020 Evaluation of a Novel Telemedicine-Based Intervention to Manage Body Image Disturbance in Head and Neck Cancer Survivors. BID
44  2020 Evaluation of a speech pathology service delivery model for patients at low dysphagia risk during radiotherapy for HNC. RT, SP
45  2020 Exhaled breath analysis in the diagnosis of head and neck cancer. EBA
46  2020 Exploring head and neck cancer patients' experiences with radiation therapy immobilisation masks: A qualitative study. ANZ
47  2020 Factors impacting on discordance with treatment plan in head and neck cancer patients: a retrospective, population-based cohort study. BSC, CT, RT
48  2020 Factors predicting for patient refusal of head and neck cancer therapy. ---
49  2020 FDG-PET/CT in the surveillance of head and neck cancer following radiotherapy. NPV
50  2020 Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study. FGI, MDSFR/SFF
51  2020 Free flap reconstruction in paediatric patients with head and neck cancer: clinical considerations for comprehensive care. ---
52  2020 Gaps in Treatment and Surveillance: Head and Neck Cancer Care in a Safety-Net Hospital. DTI
53  2020 Generalizability assessment of head and neck cancer NTCP models based on the TRIPOD criteria. NTCP
54  2020 Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma. HNSCC, ROC, SNPs
55  2020 Geographical and Racial Disparities in Head and Neck Cancer Diagnosis in South-Eastern United States: Using Real-World Electronic Medical Records Data. CI, OR
56  2020 Head and neck cancer risk calculator (HaNC-RC)-V.2. Adjustments and addition of symptoms and social history factors. AUC, HaN, HaNC-RC, USOC
57  2020 Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks. AGPs, HCWs, PPE
58  2020 Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. ---
59  2020 Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database. GO, KEGG
60  2020 Impact of Neck Disability on Health-Related Quality of Life among Head and Neck Cancer Survivors. QOL
61  2020 Impact of Time to Diagnosis and Treatment in Head and Neck Cancer: A Systematic Review. PROMs
62  2020 Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study. ELST, IMPT, OARs, RBE, RMSDs, SPArc
63  2020 In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System. AAV, CRISPR
64  2020 Individualized prediction of late-onset dysphagia in head and neck cancer survivors. ---
65  2020 Influence of remoteness of residence on timeliness of diagnosis and treatment of oral cavity and oropharynx cancer: A retrospective cohort study. SCC
66  2020 Influence of the human papillomavirus on the radio-responsiveness of cancer stem cells in head and neck cancers. CSCs
67  2020 Insurance status, stage of presentation, and survival among female patients with head and neck cancer. aHR, AOR, CI
68  2020 Is pain part of a systemic syndrome in head and neck cancer? BTcP
69  2020 Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers. LPFS, OS, QS, RT
70  2020 Latency of tobacco smoking for head and neck cancer among HPV-positive and HPV-negative individuals. HPV
71  2020 Lipid microsphere bound oxycodone for pain management in patients receiving radiotherapy for head and neck cancer. RT
72  2020 Long-term swallowing, trismus, and speech outcomes after combined chemoradiotherapy and preventive rehabilitation for head and neck cancer; 10-year plus update. CRT, QOL
73  2020 Longitudinal effects of a novel advanced pneumatic compression device on patient-reported outcomes in the management of cancer-related head and neck lymphedema: A preliminary report. APCD, HNL
74  2020 Low muscle mass is associated with early termination of chemotherapy related to toxicity in patients with head and neck cancer. SMI
75  2020 Management Practices of Head and Neck Cancer in Chinese Tertiary Care Hospitals: A Multicenter Questionnaire-Based Survey Among Oncologists. CT, ICT, LAHNC, RT
76  2020 Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer. HU
77  2020 Metachronous mediastinal and lung metastases from head and neck cancer: A case series, literature review and considerations for treatment. CSR, MMLM
78  2020 Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. AUC, MDASI-HN, RT
79  2020 Monitoring skin dose changes during image-guided helical tomotherapy for head and neck cancer patients. HT, SIB, SL
80  2020 Multilevel Associations Between Patient- and Hospital-Level Factors and In-Hospital Mortality Among Hospitalized Patients With Head and Neck Cancer. AOR
81  2020 Nutrition impact symptoms and weight loss in head and neck cancer during radiotherapy: a longitudinal study. GEE, NIS, RT, WL
82  2020 Nutrition Status and Health-Related Quality of Life Among Outpatients With Advanced Head and Neck Cancer. CRT, HRQoL, PG-SGA
83  2020 Nutritional parameters associated with hospital admissions in patients being treated for head and neck cancer. BMI, EN
84  2020 Obstructive sleep apnea in head and neck cancer survivors. OSA
85  2020 Oral examination findings, taste and smell testing during and following head and neck cancer therapy. CTCAE, STTA
86  2020 Palatal augmentation prostheses in individuals treated for head and neck cancer: Effects on speech and oral transport. PAP
87  2020 Patient Derived Models to Study Head and Neck Cancer Radiation Response. PDXs
88  2020 Patients with head and neck cancer: Are they frailer than patients with other solid malignancies? ADLs, CCI, GFI, IADLs, MMSE, ORs, QOL, TUG
89  2020 Patients' and health professionals' experience of the Danish fast track treatment pathway for head and neck cancer patients receiving oral rehabilitation. ---
90  2020 Percutaneous Endoscopic Gastrostomy Tube Placement in Patients with Head and Neck Cancer Treated with Radiotherapy. CRT, PEG, RT
91  2020 Pilot study of combined aerobic and resistance exercise on fatigue for patients with head and neck cancer: Inflammatory and epigenetic changes. 6MWD, DMS, IL, TNF-alpha
92  2020 Postimplantation radiation therapy in head and neck cancer patients: Literature review. ORN, RT
93  2020 Potential oncogenic roles of mutant-p53-derived exosomes in the tumor-host interaction of head and neck cancers. GOF, HPV, TME
94  2020 Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement. ASTRO, ESTRO
95  2020 Predicting Swallowing Outcomes from Objective Videofluoroscopic Timing and Displacement Measures in Head and Neck Cancer Patients. FOIS
96  2020 Presenting pre-radiotherapy dental status of head and neck cancer patients in the novel radiation era. RT
97  2020 Prevalence and prognostic significance of malnutrition in patients with cancers of the head and neck. DI, MLR, OS, PS, WL, WLG
98  2020 Prevalence of human papillomavirus in archival head and neck cancer in the eastern Inner Mongolian Autonomous Region, China. HPV
99  2020 Prevalence of profound laryngeal sensory neuropathy in head and neck cancer survivors with feeding tube-dependent oropharyngeal dysphagia. LSN
100  2020 Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer. ROC